RxDoctor Payments Data

Joanne Fritsche

Psychiatric/Mental Health · Canton, OHNPI 1235416603

Payments from drug & device makers

$1,282in general payments, 2019–2025

Across 77 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$375
  • Alkermes, Inc.$221
  • Teva Pharmaceuticals USA, Inc.$160
  • E.r. Squibb & Sons, L.L.C.$122
  • Neurocrine Biosciences, Inc.$96
  • Johnson & Johnson$92
  • plus $217 from 9 others

What the payments were for

  • Food & beverage$1,25598%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,282 in reported general payments places this provider in the 65th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$29,012
Medicare patients
62
Services billed
310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate19$161,789
AristadaAripiprazole Lauroxil34$127,195
UzedyRisperidone18$60,172
Invega SustennaPaliperidone Palmitate13$42,449
RexultiBrexpiprazole27$38,346
VraylarCariprazine Hcl15$22,276
Lurasidone Hcl20$6,031
Aripiprazole47$3,855
Naltrexone Hcl57$3,753
Ziprasidone Hcl29$2,238
Buspirone Hcl144$2,057
Divalproex Sodium53$1,867
Risperidone156$1,539
Duloxetine Hcl84$1,327
Bupropion XlBupropion Hcl53$1,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$96$161,78919 claims
Alkermes, Inc.Aristada$221$127,19534 claims
Teva Pharmaceuticals USA, Inc.Uzedy$160$60,17218 claims
Johnson & JohnsonInvega Sustenna$92$42,44913 claims
Otsuka America Pharmaceutical, Inc.Rexulti$70$38,34627 claims
AbbVieVraylar$375$22,27615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →